English: Thank you for your statement, Cabinet Secretary, on the new treatment fund. We look forward to receiving more concrete details in the future. Your statement mentions that the fund will provide extra funds for new medicines, but can you confirm it will also fund new treatments, for example proton beam therapy? My question on co-funding has already been answered, so I'll move on. Moving on to the independent review of the IPFR process, I would like to thank you for the inclusive way you have approached the IPFR review. It is refreshing that you have approached the IPFR review process in a non-partisan way, and panel appointments reassure me that this will be a truly independent review. It was a pleasure to meet Andrew Blakeman last week, and I would like to thank you also for facilitating that meeting. Mr Blakeman is an excellent choice as chair of the review panel, and he has assured me that this review will achieve what many previous ones have not, namely putting in place a process whereby patients can receive the best available treatment based on clinical needs. We have had reviews in the past, but nothing much has changed. But this time, I believe the panel has the expertise, and, more importantly, with the inclusion of Irfon Williams, the experience truly to understand the failings of the current system, and the ability to deliver suggestions on how we can reform the system. Thankfully, Cabinet Secretary, Andrew Blakeman answered most of my questions last week. I would just like to put on record my thanks, once again, for the way you're handling this review. I look forward to working with you to implement the review's recommendations. Far too many are, often, let down by the IPFR process, and we must ensure that we have a system in place that works for patients and clinicians. I look forward to being a part of this. Thank you.
Welsh: Diolch i chi am eich datganiad, Ysgrifennydd y Cabinet, ar y gronfa driniaethau newydd. Edrychwn ymlaen at gael manylion mwy pendant yn y dyfodol. Mae eich datganiad yn crybwyll y bydd y gronfa yn darparu arian ychwanegol ar gyfer meddyginiaethau newydd, ond a allwch chi gadarnhau y bydd hefyd yn ariannu triniaethau newydd, er enghraifft therapi pelydr proton? Atebwyd fy nghwestiwn ar gyd-ariannu eisoes, felly symudaf ymlaen. Gan symud ymlaen at yr adolygiad annibynnol o'r broses IPFR, hoffwn ddiolch ichi am y ffordd gynhwysol yr ydych wedi ymdrin â'r adolygiad IPFR. Mae'n braf eich bod wedi ymdrin â'r broses o adolygu IPFR mewn ffordd amhleidiol, ac mae penodiadau'r panel yn fy sicrhau i y bydd hwn yn adolygiad gwirioneddol annibynnol. Roedd yn bleser cyfarfod Andrew Blakeman yr wythnos diwethaf, a hoffwn ddiolch i chi hefyd am hwyluso'r cyfarfod hwnnw. Mae Mr Blakeman yn ddewis gwych fel cadeirydd y panel adolygu, ac mae wedi fy sicrhau y bydd yr adolygiad hwn yn cyflawni'r hyn nad yw llawer o rai blaenorol wedi ei gyflawni, sef sefydlu proses lle gall cleifion gael y driniaeth orau sydd ar gael ar sail anghenion clinigol. Rydym wedi cael adolygiadau yn y gorffennol, ac nid oes fawr ddim wedi newid. Ond y tro hwn, rwy'n credu bod gan y panel yr arbenigedd ac, yn bwysicach na hynny, drwy gynnwys Irfon Williams, y profiad gwirioneddol i ddeall diffygion y system bresennol, a'r gallu i gyflwyno awgrymiadau ar sut y gallwn ddiwygio'r system. Diolch byth, Ysgrifennydd y Cabinet, atebodd Andrew Blakeman y rhan fwyaf o fy nghwestiynau yr wythnos diwethaf. Hoffwn gofnodi fy niolch, unwaith eto, am y ffordd yr ydych yn ymdrin â'r adolygiad hwn. Rwy'n edrych ymlaen at weithio gyda chi i weithredu argymhellion yr adolygiad. Yn aml, mae gormod o bobl yn cael eu siomi gan y broses IPFR, a rhaid inni sicrhau bod gennym system ar waith sy'n gweithio i gleifion a chlinigwyr. Rwy'n edrych ymlaen at fod yn rhan o hyn. Diolch.